Pancreatic cancer drug trial halted over safety issues
NCT ID NCT05525286
First seen Nov 17, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study tested a new drug called SOT102, alone or with standard chemotherapy, in 31 people with advanced pancreatic cancer. The goal was to find the safest dose and see if it helped shrink tumors. However, the trial was stopped early because of unexpected safety problems that reappeared even after changes were made.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Main Campus
Cleveland, Ohio, 44195, United States
-
Hospital Universitario HM Sanchinarro
Madrid, Spain
-
Institut Gustave Roussy
Paris, France
-
Institut Jules Bordet
Brussels, Belgium
-
Masarykův Onkologický Ústav
Brno, Czechia
-
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Belgium
-
VHIO - Vall d'Hebron Institut d'Oncologia
Barcelona, Spain
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.